Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
about
Update and new approaches in the treatment of Castleman diseaseCastleman's disease of the neck: report of 4 cases with unusual presentations.Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseHIV-associated multicentric Castleman diseaseTherapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.Successful treatment of multicentric Castleman's disease accompanying myeloma with bortezomibFifty years of multicentric Castleman's disease.The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.Castleman disease.Treatment of multicentric Castleman's Disease accompanying multiple myeloma with bortezomib: a case report.Castleman's disease and HIV infection in Australia.Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome.Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor.Efficacy of bortezomib and thalidomide in the recrudescent form of multicentric mixed-type Castleman's disease.Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center.
P2860
Q26740703-F98A428E-759A-46F5-99BD-DF65BCD34C31Q34441600-B647BFD7-3BB2-44E7-AA53-C857B08C2795Q34636851-FF43F67B-D36F-47CB-9123-04113371C2CDQ35226470-A08C79B5-5F25-462F-99B4-149EFD91CE49Q35917368-29017A65-F649-4D5C-AD4C-F12D0249A328Q35979274-C9D94782-8314-4B80-A535-CB4D4C4182BEQ36069611-30C0E6E8-9256-4537-A26C-DEF022A97C50Q36085023-473D5844-0407-4A83-93DD-4FF45831DA09Q36297647-D7BD6C5C-C7AC-4118-9034-9BE80144389EQ37203038-37FA35D4-B9CD-4A75-8397-E36D779E776FQ40510854-E00A0BD5-2874-43C4-9538-094E6464A1CDQ41135124-5350700D-0B6B-4F65-B0E7-489C889E25E2Q41138046-A6551A4D-E9C4-4D1D-B860-E3AD8B9380A8Q43213062-E4A5B1F3-29AF-47C4-86A4-ED14C372FF75Q46670592-85C52FFA-6931-47EB-B088-F9C0935BC4CF
P2860
Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Alleviation of systemic manife ...... eman's disease by thalidomide.
@ast
Alleviation of systemic manife ...... eman's disease by thalidomide.
@en
type
label
Alleviation of systemic manife ...... eman's disease by thalidomide.
@ast
Alleviation of systemic manife ...... eman's disease by thalidomide.
@en
prefLabel
Alleviation of systemic manife ...... eman's disease by thalidomide.
@ast
Alleviation of systemic manife ...... eman's disease by thalidomide.
@en
P356
P1476
Alleviation of systemic manife ...... eman's disease by thalidomide.
@en
P2093
Fa-Chyi Lee
Shakil H Merchant
P356
10.1002/AJH.10310
P577
2003-05-01T00:00:00Z